Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bristol-Myers Squibb
(NY:
BMY
)
47.63
+0.12 (+0.25%)
Official Closing Price
Updated: 6:30 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
75
76
Next >
Bristol Myers' Cobenfy Falls Short On Primary Endpoint In Phase 3 Schizophrenia Trial, Stock Slides
April 23, 2025
Bristol Myers' Cobenfy missed its primary endpoint in the Phase 3 ARISE trial but showed symptom improvement in certain subgroups.
Via
Benzinga
Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect
April 23, 2025
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results tomorrow morning. Here’s what investors should know.
Via
StockStory
Bristol Myers Squibb Stock Slides After-Hours As Schizophrenia Trial Misses Goal, But Retail's Buying The Dip
April 23, 2025
A post-hoc analysis showed more pronounced effects among patients on risperidone compared to those on other antipsychotics, the company said.
Via
Stocktwits
Topics
Intellectual Property
Stay updated with the S&P500 stocks that are on the move in today's after-hours session.
April 22, 2025
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session.
Via
Chartmill
Beyond The Numbers: 7 Analysts Discuss Bristol-Myers Squibb Stock
April 22, 2025
Via
Benzinga
Bristol Myers Sheds 6% After Promising Schizophrenia Drug Flops In Phase 3 Test
April 22, 2025
The company spent $14 billion to acquire the developer of this drug, Cobenfy.
Via
Investor's Business Daily
Bristol Myers Squibb Announces Topline Results from Phase 3 ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia
April 22, 2025
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Analyst Says FDA Update Is A Win For Camzyos With Simpler Use, Broader Reach
April 21, 2025
FDA approves Camzyos label update easing echo monitoring and lifting drug interaction limits, supported by 3.5 years of safety data and real-world use
Via
Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
April 21, 2025
Via
Benzinga
U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
April 17, 2025
From
Bristol Myers Squibb
Via
Business Wire
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
April 17, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
April 16, 2025
Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug prices, aligning payments with hospital acquisition costs, and investigating...
Via
Benzinga
Topics
Government
Why Is US Pharma Giant Bristol Myers Squibb Stock Trading Lower On Tuesday?
April 15, 2025
Bristol Myers' Camzyos missed goals in a Phase 3 nHCM trial, showing no significant benefits over placebo but raised no new safety concerns.
Via
Benzinga
Which S&P500 stocks are moving on Tuesday?
April 15, 2025
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.
Via
Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
April 15, 2025
Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.
Via
Chartmill
Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It
April 14, 2025
The companies are facing off with their heart drugs in a growing disease area.
Via
Investor's Business Daily
Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial
April 14, 2025
From
Bristol Myers Squibb
Via
Business Wire
These Large-Cap Stocks With China And EU Exposure Got Crushed In The One Of The Most Volatile Trading Week (Apr 7-Apr 11): Are These In Your Portfolio?
April 13, 2025
Large-cap stocks, such as PDD, PBR, KMX, APTV, STLA, CRWV, BMY, Z, BABA, and YUMC, saw significant declines due to trade tensions and missed earnings.
Via
Benzinga
Topics
World Trade
Why BRISTOL-MYERS SQUIBB CO (NYSE:BMY) qualifies as a good dividend investing stock.
April 12, 2025
Analyzing BRISTOL-MYERS SQUIBB CO (NYSE:BMY)'s Dividend Potential.
Via
Chartmill
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
April 11, 2025
From
Bristol Myers Squibb
Via
Business Wire
Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight
April 11, 2025
Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in preclinical studies targeting leukemia cells.
Via
Benzinga
3 Value Stocks in the Doghouse
April 11, 2025
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...
Via
StockStory
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
Via
Benzinga
Topics
Government
World Trade
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
April 10, 2025
Here's why the 90-day tariffs delay doesn't help pharmaceutical companies.
Via
Investor's Business Daily
Topics
Government
Stocks
World Trade
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
April 10, 2025
Tempest Therapeutics hires MTS Health to explore M&A and partnerships after Roche shows limited interest in its liver cancer program.
Via
Benzinga
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks
April 10, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Eli Lilly (NYSE:LLY) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
What's going on in today's session: S&P500 movers
April 09, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.
Via
Chartmill
These S&P500 stocks are gapping in today's session
April 09, 2025
Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.
Via
Chartmill
Tech Stocks Rebound As US Treasuries Tumble: What's Driving Markets Wednesday?
April 09, 2025
Wall Street saw a tentative tech rebound early Wednesday, as investors begin to shrug off escalating U.S.-China trade tensions following a steep market selloff.
Via
Benzinga
Topics
World Trade
FDA Approves Bristol Myers' Opdivo Plus Yervoy Combo For Untreated Colorectal Cancer Patients
April 09, 2025
The FDA has approved Opdivo plus Yervoy for the first-line treatment of MSI-H/dMMR colorectal cancer, supported by the Phase 3 CheckMate-8HW trial results.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
75
76
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.